Literature DB >> 4202339

Protein synthesis in Mycobacterium tuberculosis H37Rv and the effect of streptomycin in streptomycin-susceptible and -resistant strains.

M S Shaila, K P Gopinathan, T Ramakrishnan.   

Abstract

An efficient in vitro amino acid-incorporating system from Mycobacterium tuberculosis H37Rv was standardized. Ribonucleic acid (RNA) isolated from phage-infected M. smegmatis cells served as natural messenger RNA and directed the incorporation of (14)C-amino acids into protein. The effects of various antitubercular drugs and "known inhibitors" of protein synthesis on amino acid incorporation were studied. Antibiotics like chloramphenicol and tetracycline inhibited mycobacterial protein synthesis, though they failed to prevent the growth of the organism. This failure was shown to be due to the impermeability of mycobacteria to these drugs by use of "membrane-active" agents along with the antibiotics in growth inhibition studies. Several independent streptomycin-resistant mutants of M. tuberculosis H37Rv were isolated. Streptomycin inhibited the incorporation of (14)C-amino acids into proteins by whole cells of a streptomycin-susceptible strain by more than 90%, whereas very little or no inhibition was observed in either high-level or low-level streptomycin-resistant strains. In vitro, streptomycin was an effective inhibitor of susceptible strains, whereas in streptomycin-resistant strains the concentration of streptomycin at which half-maximal inhibition was produced varied according to the resistance of whole cells, and there was a correlation between the two. In one low-level streptomycin-resistant mutant, the in vitro amino acid-incorporating system was as sensitive to various concentrations of streptomycin as the parental type, and a possible involvement of a membrane site in the development of low-level resistance was indicated. Streptomycin susceptibility and high-level resistance were shown to be ribosomal in nature.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4202339      PMCID: PMC444530          DOI: 10.1128/AAC.4.3.205

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Inhibition of polypeptide synthesis by streptomycin.

Authors:  J G FLAKS; E C COX; J R WHITE
Journal:  Biochem Biophys Res Commun       Date:  1962-05-11       Impact factor: 3.575

Review 2.  Intermediary metabolism of mycobacteria.

Authors:  T Ramakrishnan; P S Murthy; K P Gopinathan
Journal:  Bacteriol Rev       Date:  1972-03

3.  Levels of resistance in ribosomes from genetically linked, streptomycin-resistant mutants of pneumococcus.

Authors:  J J Stuart; A W Ravin
Journal:  J Gen Microbiol       Date:  1968-05

4.  Proteosynthetic activity of isolated ribosomes of Mycobacteria and its alteration by rifampicin and related tuberculostatic drugs.

Authors:  L Trnka; D W Smith
Journal:  Antibiot Chemother       Date:  1970

5.  The surface structure of Escherichia coli.

Authors:  M E Bayer; T F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1965-12       Impact factor: 11.205

6.  Transduction in Mycobacterium smegmatis.

Authors:  C V Raj; T Ramakrishnan
Journal:  Nature       Date:  1970-10-17       Impact factor: 49.962

7.  Effect of isoniazid on mycobacterial polyphenylalanine synthesis.

Authors:  M Rieber; T Imaeda
Journal:  Biochim Biophys Acta       Date:  1969-07-22

Review 8.  Inhibitors of ribosome functions.

Authors:  S Pestka
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

9.  In vitro synthesis of bacteriophage lysozyme.

Authors:  W Salser; R F Gesteland; A Bolle
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

10.  Isoniazid-resistant mutants of Mycobacterium tuberculosis H37RV: uptake of isoniazid and the properties of NADase inhibitor.

Authors:  K S Sriprakash; T Ramakrishnan
Journal:  J Gen Microbiol       Date:  1970-01
View more
  8 in total

1.  Purification and Some Biological Properties of Asparaginase from Azotobacter vinelandii.

Authors:  S A Gaffar; Y I Shethna
Journal:  Appl Environ Microbiol       Date:  1977-03       Impact factor: 4.792

2.  Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis.

Authors:  A Meier; P Sander; K J Schaper; M Scholz; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  T Yamada; A Nagata; Y Ono; Y Suzuki; T Yamanouchi
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

4.  Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance.

Authors:  A Meier; P Kirschner; F C Bange; U Vogel; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 5.  Physiology of mycobacteria.

Authors:  Gregory M Cook; Michael Berney; Susanne Gebhard; Matthias Heinemann; Robert A Cox; Olga Danilchanka; Michael Niederweis
Journal:  Adv Microb Physiol       Date:  2009       Impact factor: 3.517

6.  Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.

Authors:  Sabine Ehrt; Xinzheng V Guo; Christopher M Hickey; Marvin Ryou; Mercedes Monteleone; Lee W Riley; Dirk Schnappinger
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

7.  mRNA Degradation Rates Are Coupled to Metabolic Status in Mycobacterium smegmatis.

Authors:  Diego A Vargas-Blanco; Ying Zhou; L Gregory Zamalloa; Tim Antonelli; Scarlet S Shell
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

Review 8.  Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.

Authors:  A Rattan; A Kalia; N Ahmad
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.